forty consecutive psychiatric patients referred to hospital with a diagnosis of depressive illness were randomly allocated to double-blind treatment with either 50 mg sustained-release amitriptyline or 75 mg maprotiline in night-time dosage .
C0011581
depressive illness
C0002600
amitriptyline